AARTIDRUGSNSEAarti Drugs Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 18 May · 15:55 IST

Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.1%1-day move
₹366.05
prior close
₹365.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.5+2.4+3.1+2.9+4.1+3.8+6.4+7.8+7.3+3.5+1.8+1.1+14.6
Up moveDown movePending
AI summary

Aarti Drugs Limited has filed a notification with NSE and BSE informing about the publication of its Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 2026. The results were published in Financial Express (English) and Pratahkal (Marathi) newspapers on Sunday, May 17, 2026. This filing is pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to publish quarterly and annual financial results in newspapers. The actual financial figures are not included in this notification; this is merely a compliance intimation confirming where the results were published.

Likely market impact

This is a routine regulatory compliance filing. The actual financial results, which would determine impact on the stock, are published separately in the newspapers. Shareholders should refer to the published results for detailed financial performance assessment.